Skip to content
healthcare.dev

COSELA

NDC 73594-0101, trilaciclib, injection, powder, lyophilized, for solution, from Pharmacosmos Therapeutics Inc..

Product NDC
73594-0101
Status
Listed
Labeler
Pharmacosmos Therapeutics Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214200
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73594-0101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRILACICLIB DIHYDROCHLORIDE300 mg/20mL

Pharmacologic classes

Cyclin-dependent Kinase 4 Inhibitors [MoA]; Cyclin-dependent Kinase 6 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
73594-0101-1735940101011 VIAL, GLASS in 1 CARTON (73594-0101-1) / 20 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b3179c19-78f3-4bf1-b73e-7f7638522ab1
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=73594-0101

Use it

Look up 73594-0101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73594-0101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73594-0101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.